Status:
WITHDRAWN
Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing
Lead Sponsor:
Stanford University
Conditions:
Scleroderma
Dysphagia
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
FLIP topography has been FDA cleared to evaluate a variety of esophageal conditions, but has never been evaluated in patients with scleroderma. The investigators hope to evaluate this technology in pa...
Detailed Description
In patients with treatment refractory reflux disease, dysphagia (trouble swallowing) or other symptoms possibly attributed to the esophagus, the standard protocol is generally to first do an upper end...
Eligibility Criteria
Inclusion
- Must have a clinical indication for upper endoscopy (recruiting patients both with scleroderma and without)
Exclusion
- not healthy enough to undergo an upper endoscopy
- mass, stricture, ring, or web present on upper endoscopy
- history of esophageal cancer
- history of esophageal surgery
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03270722
Start Date
January 1 2018
End Date
May 1 2020
Last Update
January 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Healthcare
Redwood City, California, United States, 94063